Page 19 - GTM-3-3

Global Translational Medicine Influence of estrogen on RV mitochondria in PH

doi: 10.1016/j.ccl.2016.04.001 14. Mair KM, Johansen AKZ, Wright AF, Wallace E,
MacLean MR. Pulmonary arterial hypertension: Basis of
4. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in
patients with primary pulmonary hypertension. Results sex differences in incidence and treatment response. Br J
from a national prospective registry. Ann Intern Med. Pharmacol. 2014;171(3):567-579.
1991;115(5):343-349. doi: 10.1111/bph.12281
doi: 10.7326/0003-4819-115-5-343 15. Shapiro S, Traiger GL, Turner M, McGoon MD, Wason P,
Barst RJ. Sex differences in the diagnosis, treatment, and
5. Korsholm K, Andersen A, Kirkfeldt RE, Hansen KN,
Mellemkjær S, Nielsen-Kudsk JE. Survival in an incident outcome of patients with pulmonary arterial hypertension
cohort of patients with pulmonary arterial hypertension in enrolled in the registry to evaluate early and long-term
Denmark. Pulm Circ. 2015;5(2):364-369. pulmonary arterial hypertension disease management.
Chest. 2012;141(2):363-373.
doi: 10.1086/681270
doi: 10.1378/chest.10-3114
6. Farber HW, Miller DP, Poms AD, et al. Five-year outcomes
of patients enrolled in the REVEAL registry. Chest. 16. Walker AM, Langleben D, Korelitz JJ, et al. Temporal
2015;148(4):1043-1054. trends and drug exposures in pulmonary hypertension: An
American experience. Am Heart J. 2006;152(3):521-526.
doi: 10.1378/chest.15-0300
doi: 10.1016/j.ahj.2006.02.020
7. Chang KY, Duval S, Badesch DB, et al. Mortality in
pulmonary arterial hypertension in the modern era: Early 17. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary
Insights from the pulmonary hypertension association arterial hypertension: Baseline characteristics from the
registry. J Am Heart Assoc. 2022;11(9):e024969. REVEAL Registry. Chest. 2010;137(2):376-387.
doi: 10.1378/chest.09-1140
doi: 10.1161/jaha.121.024969
18. Keen J, Prisco SZ, Prins KW. Sex differences in right
8. Chen X, Quan R, Qian Y, et al. 10-year survival of
pulmonary arterial hypertension associated with connective ventricular dysfunction: Insights from the bench to bedside.
tissue disease: Insights from a multicentre PAH registry. Front Physiol. 2020;11:623129.
Rheumatology (Oxford). 2023;62(11):3555-3564. doi: 10.3389/fphys.2020.623129
doi: 10.1093/rheumatology/kead103 19. Ventetuolo CE, Moutchia J, Baird GL, et al. Baseline sex
differences in pulmonary arterial hypertension randomized
9. Ghio S, Klersy C, Magrini G, et al. Prognostic relevance
of the echocardiographic assessment of right ventricular clinical trials. Ann Am Thorac Soc. 2023;20(1):58-66.
function in patients with idiopathic pulmonary arterial doi: 10.1513/AnnalsATS.202203-207OC
hypertension. Int J Cardiol. 2010;140(3):272-278.
20. Dignam JP, Sharma S, Stasinopoulos I, MacLean MR.
doi: 10.1016/j.ijcard.2008.11.051 Pulmonary arterial hypertension: Sex matters. Br J
Pharmacol. 2024;181(7):938-966.
10. Voelkel NF, Bogaard HJ, Gomez-Arroyo J. The need to
recognize the pulmonary circulation and the right ventricle doi: 10.1111/bph.16277
as an integrated functional unit: Facts and hypotheses (2013 21. Lahm T, Tuder RM, Petrache I. Progress in solving the sex
Grover Conference series). Pulm Circ. 2015;5(1):81-89.
hormone paradox in pulmonary hypertension. Am J Physiol
doi: 10.1086/679702 Lung Cell Mol Physiol. 2014;307(1):L7-L26.
11. Tello K, Richter MJ, Yogeswaran A, et al. Sex differences doi: 10.1152/ajplung.00337.2013
in right ventricular-pulmonary arterial coupling in 22. Foderaro A, Ventetuolo CE. Pulmonary arterial
pulmonary arterial hypertension. Am J Respir Crit Care hypertension and the sex hormone paradox. Curr Hypertens
Med. 2020;202(7):1042-1046.
Rep. 2016;18(11):84.
doi: 10.1164/rccm.202003-0807LE
doi: 10.1007/s11906-016-0689-7
12. He Q, Lin Y, Zhu Y, et al. Clinical usefulness of right ventricle- 23. Morris H, Denver N, Gaw R, Labazi H, Mair K, MacLean MR.
pulmonary artery coupling in cardiovascular disease. J Clin Sex differences in pulmonary hypertension. Clin Chest Med.
Med. 2023;12(7):2526.
2021;42(1):217-228.
doi: 10.3390/jcm12072526
doi: 10.1016/j.ccm.2020.10.005
13. Egbe AC, Kothapalli S, Miranda WR, et al. Assessment of 24. Austin ED, Cogan JD, West JD, et al. Alterations in oestrogen
right ventricular-pulmonary arterial coupling in chronic metabolism: Implications for higher penetrance of familial
pulmonary regurgitation. Can J Cardiol. 2019;35(7):914-922.
pulmonary arterial hypertension in females. Eur Respir J.
doi: 10.1016/j.cjca.2019.03.009 2009;34(5):1093-1039.

Volume 3 Issue 3 (2024) 9 doi: 10.36922/gtm.2494